Elisabeth J. Vinke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elisabeth J. Vinke has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Meike Willemijn Vernooij
Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands
6 shared publications - Mohammad Arfan Ikram
Erasmus MC University Medical Center, Rotterdam, The Netherlands
4 shared publications - Esther E. Bron
Biomedical Imaging Group Rotterdam, Department of Radiology & Nuclear Medicine, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands
2 shared publications - Geert Jan Biessels
Department of Neurology, University Medical Center Utrecht, Utrecht, The Netherlands
2 shared publications - Alexa S. Beiser
NHLBI’s Framingham Heart Study, Framingham, MA
1 shared publication - Bastian Cheng
Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
1 shared publication
Latest Publications
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 2 (3) , e000120
Atrophy Patterns Across Dementia Etiologies Assessed by MRI-Based Clustering of a Memory Clinic Population
Background and ObjectivesIn clinical practice, it is difficult to accurately diagnose dementia etiologies, although brain MRI has strong diagnostic potential. Unsupervised data-driven methods can p...
- 1 September 2026
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 2 (3) , e000120
Open AccessAtrophy Patterns Across Dementia Etiologies Assessed by MRI-Based Clustering of a Memory Clinic Population
Background and ObjectivesIn clinical practice, it is difficult to accurately diagnose dementia etiologies, although brain MRI has strong diagnostic potential. Unsupervised data-driven methods can p...
- Open Access
- 17 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (6) , e041316
Incidence and Prognostic Indicators of Dementia in Patients With Covert Brain Infarction, Transient Ischemic Attack, and Stroke: The Population‐Based Rotterdam Study
Background: Cognitive impairment is common after transient ischemic attack (TIA) and stroke, but contemporary population‐representative estimates of dementia risk after stroke are scarce, particularly in view of stroke severity and competing risk of mortality. Methods: We included individuals from the population‐based Rotterdam Study with first‐ever covert brain infarction (n=630), TIA (n=547), minor stroke (National Institutes of Health Stroke Scale score APOE ‐ε4‐carriership, hypercholesterolemia, and on neuroimaging hippocampal and white matter hyperintensities volume, cortical thickness, and ≥2 cerebral microbleeds. Conclusions: Dementia risk is elevated after stroke, and to a lesser extent covert brain infarction, but not after TIA. Excess risk extends to long‐term follow‐up for minor stroke, whereas competing risk of death attenuates risk after major stroke. Clinical and imaging indicators hold potential for personalized estimation of dementia risk.
- 17 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (6) , e041316
Open AccessIncidence and Prognostic Indicators of Dementia in Patients With Covert Brain Infarction, Transient Ischemic Attack, and Stroke: The Population‐Based Rotterdam Study
Background: Cognitive impairment is common after transient ischemic attack (TIA) and stroke, but contemporary population‐representative estimates of dementia risk after stroke are scarce, particularly in view of stroke severity and competing risk of mortality. Methods: We included individuals from the population‐based Rotterdam Study with first‐ever covert brain infarction (n=630), TIA (n=547), minor stroke (National Institutes of Health Stroke Scale score APOE ‐ε4‐carriership, hypercholesterolemia, and on neuroimaging hippocampal and white matter hyperintensities volume, cortical thickness, and ≥2 cerebral microbleeds. Conclusions: Dementia risk is elevated after stroke, and to a lesser extent covert brain infarction, but not after TIA. Excess risk extends to long‐term follow‐up for minor stroke, whereas competing risk of death attenuates risk after major stroke. Clinical and imaging indicators hold potential for personalized estimation of dementia risk.
- Open Access
- 1 October 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (10) , 3047-3059
Signature White Matter Hyperintensity Locations Associated With Vascular Risk Factors Derived From 15 653 Individuals
BACKGROUND: White matter hyperintensities (WMHs) of presumed vascular origin are common in the elderly and are associated with vascular risk factors. There is evidence that vascular risk factors, in particular hypertension, are associated with WMH in particular locations of the white matter. However, it remains unclear whether this is true for all risk factors and whether signature WMH locations differ between risk factors. We aimed to identify WMH locations associated with vascular risk factors in community-dwelling individuals. METHODS: We pooled cross-sectional data from 16 population-based cohorts (15 653 individuals; mean age, 64.2±11.8 years; 52.2% female) through the Meta VCI Map Consortium. We quantified associations between WMH volumes in 50 white matter regions and 6 vascular risk factors using linear mixed models. Analyses were corrected for age, sex, study site, and total WMH volume. RESULTS: Hypertension (B=0.141; P P P P =0.034) were significantly associated with higher total WMH volume, whereas obesity (B=0.023; P =0.139) and hypercholesterolemia (B=0.009; P =0.531) were not. After correcting for total WMH volume, hypertension was associated with WMH volume in 10 regions (ie, bilateral external capsule, superior longitudinal fasciculus, superior corona radiata, anterior limb of the internal capsule, left anterior corona radiata, and left superior fronto-occipital fasciculus), smoking (body corpus callosum), diabetes (genu corpus callosum), and obesity (left inferior fronto-occipital fasciculus), each with one region. CONCLUSIONS: Hypertension has a signature WMH pattern, whereas associations between other vascular risk factors and regional WMH volumes seem to be mainly explained by a global increase in WMH rather than region-specific effects.
- 1 October 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (10) , 3047-3059
Open AccessSignature White Matter Hyperintensity Locations Associated With Vascular Risk Factors Derived From 15 653 Individuals
BACKGROUND: White matter hyperintensities (WMHs) of presumed vascular origin are common in the elderly and are associated with vascular risk factors. There is evidence that vascular risk factors, in particular hypertension, are associated with WMH in particular locations of the white matter. However, it remains unclear whether this is true for all risk factors and whether signature WMH locations differ between risk factors. We aimed to identify WMH locations associated with vascular risk factors in community-dwelling individuals. METHODS: We pooled cross-sectional data from 16 population-based cohorts (15 653 individuals; mean age, 64.2±11.8 years; 52.2% female) through the Meta VCI Map Consortium. We quantified associations between WMH volumes in 50 white matter regions and 6 vascular risk factors using linear mixed models. Analyses were corrected for age, sex, study site, and total WMH volume. RESULTS: Hypertension (B=0.141; P P P P =0.034) were significantly associated with higher total WMH volume, whereas obesity (B=0.023; P =0.139) and hypercholesterolemia (B=0.009; P =0.531) were not. After correcting for total WMH volume, hypertension was associated with WMH volume in 10 regions (ie, bilateral external capsule, superior longitudinal fasciculus, superior corona radiata, anterior limb of the internal capsule, left anterior corona radiata, and left superior fronto-occipital fasciculus), smoking (body corpus callosum), diabetes (genu corpus callosum), and obesity (left inferior fronto-occipital fasciculus), each with one region. CONCLUSIONS: Hypertension has a signature WMH pattern, whereas associations between other vascular risk factors and regional WMH volumes seem to be mainly explained by a global increase in WMH rather than region-specific effects.
- 1 December 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (12) , 2863-2871
Normative Population–Derived Data for MRI Manifestations of Cerebral Small Vessel Disease
BACKGROUND: Cerebral small vessel disease (SVD) is manifested on magnetic resonance imaging (MRI) by white matter hyperintensities, lacunes, microbleeds, and atrophy. While these manifestations can be part of normal aging, a high burden has been associated with cognitive impairment and vascular events. Distinguishing between normal versus abnormal SVD lesion burden in clinical practice remains complex. Our objective is to establish age- and sex-specific normative data for MRI manifestations of SVD, to support clinical assessment in individual patients. METHODS: We used 11 465 MRI scans from 5402 participants of the Rotterdam Study, the Netherlands, an ongoing prospective population-based cohort since 1990, to develop percentile curves for white matter hyperintensities and brain parenchymal fraction and probability curves for the prevalence and count of lacunes and microbleeds, across ages 45 to 100 years, stratified by sex. RESULTS: Participants were primarily White (≈97%), with a mean age at first scan of 64.7 (range, 45.7–97.9) years, and 55.7% being female participants. For all SVD MRI manifestations, the curves demonstrated nonlinear trends, with accelerating burden with advancing age (eg, doubling of white matter hyperintensity fraction every 10 years). Regarding brain parenchymal fraction, a decline was seen earlier in male participants (≈45 years) than female participants (≈60 years) and was more pronounced in male participants over time. Female participants had slightly higher white matter hyperintensity fractions compared with male participants across all ages. Lacunes and microbleeds were more frequently found in male participants than in female participants, and microbleeds were more prevalent than lacunes. CONCLUSIONS: We provide comprehensive normative data for different MRI manifestations of SVD, presented as percentile and probability curves by age, stratified by sex. This can aid clinicians to actually quantify the SVD burden on an individual patient’s MRI scans and detect patterns of abnormality.
- 1 December 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (12) , 2863-2871
Normative Population–Derived Data for MRI Manifestations of Cerebral Small Vessel Disease
BACKGROUND: Cerebral small vessel disease (SVD) is manifested on magnetic resonance imaging (MRI) by white matter hyperintensities, lacunes, microbleeds, and atrophy. While these manifestations can be part of normal aging, a high burden has been associated with cognitive impairment and vascular events. Distinguishing between normal versus abnormal SVD lesion burden in clinical practice remains complex. Our objective is to establish age- and sex-specific normative data for MRI manifestations of SVD, to support clinical assessment in individual patients. METHODS: We used 11 465 MRI scans from 5402 participants of the Rotterdam Study, the Netherlands, an ongoing prospective population-based cohort since 1990, to develop percentile curves for white matter hyperintensities and brain parenchymal fraction and probability curves for the prevalence and count of lacunes and microbleeds, across ages 45 to 100 years, stratified by sex. RESULTS: Participants were primarily White (≈97%), with a mean age at first scan of 64.7 (range, 45.7–97.9) years, and 55.7% being female participants. For all SVD MRI manifestations, the curves demonstrated nonlinear trends, with accelerating burden with advancing age (eg, doubling of white matter hyperintensity fraction every 10 years). Regarding brain parenchymal fraction, a decline was seen earlier in male participants (≈45 years) than female participants (≈60 years) and was more pronounced in male participants over time. Female participants had slightly higher white matter hyperintensity fractions compared with male participants across all ages. Lacunes and microbleeds were more frequently found in male participants than in female participants, and microbleeds were more prevalent than lacunes. CONCLUSIONS: We provide comprehensive normative data for different MRI manifestations of SVD, presented as percentile and probability curves by age, stratified by sex. This can aid clinicians to actually quantify the SVD burden on an individual patient’s MRI scans and detect patterns of abnormality.
- Open Access
- 3 August 2023
- Published by Springer Nature in GeroScience
- Vol. 46 (1) , 57-70
Plasma neurofilament light chain in relation to 10-year change in cognition and neuroimaging markers: a population-based study
Neurofilament light chain (NfL) is a promising biomarker for risk stratification and disease monitoring of dementia, but its utility in the preclinical disease stage remains uncertain. We determined the association of plasma NfL with (change in) neuroimaging markers and cognition in the population-based Rotterdam Study, using linear and logistic regression and mixed-effects models. Plasma NfL levels were measured using the Simoa NF-light™ assay in 4705 dementia-free participants (mean age 71.9 years, 57% women), who underwent cognitive assessment and brain MRI with repeated assessments over a 10-year follow-up period. Higher plasma NfL was associated with worse cognitive performance at baseline (g-factor: β = − 0.12 (− 0.15; − 0.09), p < 0.001), and accelerated cognitive decline during follow-up on the Stroop color naming task (β = 0.04 (0.02; 0.06), p < 0.001), with a smaller trend for decline in global cognition (g-factor β = − 0.02 (− 0.04; 0.00), p = 0.044). In the subset of 975 participants with brain MRI, higher NfL was associated with poorer baseline white matter integrity (e.g., global mean diffusivity: β = 0.12 (0.06; 0.19), p < 0.001), with similar trends for volume of white matter hyperintensities (β = 0.09 (0.02; 0.16), p = 0.011) and presence of lacunes (OR = 1.55 (1.13; 2.14), p = 0.007). Plasma NfL was not associated with volumes or thickness of the total gray matter, hippocampus, or Alzheimer signature regions. In conclusion, higher plasma NfL levels are associated with cognitive decline and larger burden of primarily white matter pathology in the general population.
- 3 August 2023
- Published by Springer Nature in GeroScience
- Vol. 46 (1) , 57-70
Open AccessPlasma neurofilament light chain in relation to 10-year change in cognition and neuroimaging markers: a population-based study
Neurofilament light chain (NfL) is a promising biomarker for risk stratification and disease monitoring of dementia, but its utility in the preclinical disease stage remains uncertain. We determined the association of plasma NfL with (change in) neuroimaging markers and cognition in the population-based Rotterdam Study, using linear and logistic regression and mixed-effects models. Plasma NfL levels were measured using the Simoa NF-light™ assay in 4705 dementia-free participants (mean age 71.9 years, 57% women), who underwent cognitive assessment and brain MRI with repeated assessments over a 10-year follow-up period. Higher plasma NfL was associated with worse cognitive performance at baseline (g-factor: β = − 0.12 (− 0.15; − 0.09), p < 0.001), and accelerated cognitive decline during follow-up on the Stroop color naming task (β = 0.04 (0.02; 0.06), p < 0.001), with a smaller trend for decline in global cognition (g-factor β = − 0.02 (− 0.04; 0.00), p = 0.044). In the subset of 975 participants with brain MRI, higher NfL was associated with poorer baseline white matter integrity (e.g., global mean diffusivity: β = 0.12 (0.06; 0.19), p < 0.001), with similar trends for volume of white matter hyperintensities (β = 0.09 (0.02; 0.16), p = 0.011) and presence of lacunes (OR = 1.55 (1.13; 2.14), p = 0.007). Plasma NfL was not associated with volumes or thickness of the total gray matter, hippocampus, or Alzheimer signature regions. In conclusion, higher plasma NfL levels are associated with cognitive decline and larger burden of primarily white matter pathology in the general population.
- Open Access
- 1 September 2021
- Published by Elsevier in Neurobiology of Aging
- Vol. 105, 16-24
Intracranial arteriosclerosis is related to cerebral small vessel disease: a prospective cohort study
- 1 September 2021
- Published by Elsevier in Neurobiology of Aging
- Vol. 105, 16-24
Open AccessIntracranial arteriosclerosis is related to cerebral small vessel disease: a prospective cohort study
- Open Access
- 1 February 2017
- Published by Elsevier in Resuscitation
- Vol. 111, 110-115
Low spontaneous variability in cerebral blood flow velocity in non-survivors after cardiac arrest
- 1 February 2017
- Published by Elsevier in Resuscitation
- Vol. 111, 110-115
Open AccessLow spontaneous variability in cerebral blood flow velocity in non-survivors after cardiac arrest